This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michelle M.

Please provide your email address to receive an email when new articles are posted on . Genetic risk for dilated cardiomyopathy was tied to elevated risk for secondary cardiomyopathies related to ...

The All of Us study showed a 0.7% prevalence of known-pathogenic or likely pathogenic variants in cardiomyopathy genes in the U.S. general population. A greater prevalence was reported for individuals ...

A national, UB-led study on genes in pediatric cardiomyopathy demonstrates strong evidence for routine genetic screening in children with the disease. The study, published April 28 in the Journal of ...

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...

A potentially life-changing heart condition, dilated cardiomyopathy, can be caused by the cumulative influence of hundreds or thousands of genes and not just by a single "aberrant" genetic variant, as ...

The Genetic Cardiomyopathy Awareness Consortium, which is part of the DCM Foundation, announced the launch of the Genetic Cardiomyopathy Patient Registry during a webinar on January 22, 2025. The ...

Scientists at St. Jude Children’s Research Hospital studied how common and rare genetic variants influence late-onset cardiomyopathy risk, highlighting the unique genetic complexity of childhood ...

Nearly 40% of NDLVC patients showed significant disease progression over long-term follow-up, highlighting the condition's clinical relevance and need for further study. Key predictors of adverse ...

Hypertrophic cardiomyopathy is a cardiovascular condition many people in Maryland are living with but to the public, it is ...